Drug Shortage Report for NEVANAC
Report ID | 47334 |
Drug Identification Number | 02308983 |
Brand name | NEVANAC |
Common or Proper name | NEVANAC SUSP 5ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | NEPAFENAC |
Strength(s) | 0.1% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-04-27 |
Estimated end date | 2018-05-14 |
Actual end date | 2018-05-24 |
Shortage status | Resolved |
Updated date | 2018-05-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-05-25 | English | Compare |
v5 | 2018-05-24 | French | Compare |
v4 | 2018-05-24 | English | Compare |
v3 | 2018-04-28 | English | Compare |
v2 | 2018-04-27 | French | Compare |
v1 | 2018-04-27 | English | Compare |
Showing 1 to 6 of 6